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Abstract
Introduction: Smartphone-compatible blood pressure devices may be a good alternative to enable self-measurement of blood
pressure by patients. Furthermore, automatic transferral of data to the hospital allows for remote monitoring. To our know-
ledge, no study has compared four of these smartphone-compatible blood pressure devices.
Methods: Patients who were followed up for acute myocardial infarction were asked to participate during their outpatient
clinic visit. After five minutes of rest, six blood pressure devices were applied. The order was randomised. Four devices were
smartphone-compatible. One device was an automated oscillometric device. One device was a handheld aneroid sphygmo-
manometer (reference device). All measurements were compared using a linear mixed model.
Results: A total of 43 patients (62.7 11.3 years, 79% male) were included. Compared to the reference device, four blood
pressure monitors yielded a significant higher mean systolic blood pressure and four monitors yielded a significant higher
diastolic BP. One device yielded a non-significant lower mean systolic blood pressure and one device yielded a non-significant
higher mean diastolic blood pressure. Except for one blood pressure device, all mean differences were smaller than 5 mmHg.
Conclusion: In this study, average inter-device variability was shown to be statistically significant, however four devices
remained within the predefined range of 5 mmHg for both systolic and diastolic blood pressures.
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Introduction
Blood pressure (BP) measurement is inevitable in BP con-
trol, which is considered a cornerstone in the primary
and secondary prevention of cardiovascular disease.1 BP
measurement is classically done by a trained healthcare
professional using a mercury sphygmomanometer and a
stethoscope to generate and auscultate the Korotkoff
sounds.2 Although this method is considered the gold
standard, it has some disadvantages: first, involvement
of a physician brings in the so-called ‘white coat hyperten-
sion’ phenomenon, in which the BP significantly rises in
the presence of a physician.3 Due to this phenomenon, the
office BP measurement could inadequately represent
the patient’s BP.3 Second, patients often have to come
to the outpatient clinic, making the measurement time-
consuming and a burden to the patient. Lastly, due to
the necessity of the presence of a healthcare professional
and an outpatient clinic, it is costs more than home BP
measurement.4
An alternative to outpatient clinic BP measurement is
home BP measurement, in which patients use an auto-
mated device to measure their BP at home without the
presence of trained healthcare staff. Home BP measure-
ment has advantages, as patients do not have to go to the
outpatient clinic and it bypasses the white coat hyperten-
sion phenomenon.5 For these reasons, the European
Hypertension Society guidelines stress the importance of
the use of home BP measurement noting that, using home
BP measuring, cardiovascular morbidity and mortality
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can be predicted significantly better than with office
measurements.5
Furthermore, it was recently demonstrated that home
BP monitoring with antihypertensive treatment adjust-
ments by pharmacists even improved BP control com-
pared to usual care.6
Over the past few years, smartphone-compatible oscil-
lometric BP monitors have been approved for over-
the-counter sale in the European Union.7–9 These BP
monitors can be applied by the patient without the pres-
ence of trained healthcare professionals. Furthermore, the
storage of data in the Cloud allows for easy and automatic
transferral to healthcare professionals.7–9 Thus, these
smartphone-compatible BP monitors could be used for
more frequent measurements, without the presence or
assistance of a trained healthcare professional and the
necessity of an outpatient clinic. These features make
these smartphone-compatible BP monitors suitable for
telemedicine. So far, most studies have focused on
the validation of one smartphone-compatible device in
healthy volunteers.10–13 To our knowledge, no study has
yet compared the performances of these four smartphone-
compatible monitors in a population with a doctor-
confirmed cardiovascular disease. Therefore, the aim of
this study is to compare the intra- and inter-device vari-
ability of four smartphone compatible BP monitors with
an aneroid sphygmomanometer and an automated, non-
smartphone compatible, oscillometric monitor in a popu-
lation with recent acute myocardial infarction (AMI).
Methods
Patient population
Patients with recent (<1 year) AMI visiting the outpatient
clinic as part of the follow-up of their AMI were
approached to participate in the study. Patients were
excluded if they had had a documented history of an
irregular heart rhythm (e.g. atrial fibrillation, atrial flutter,
Mobitz II or grade III atrioventricular-block).
Furthermore, patients were excluded if they were con-
sidered an incapacitated adult, if they were pregnant or
if they were unwilling to sign the informed consent form.
Patients who did not own a smartphone were not excluded
for this study.
BP monitors
Details on the methods of this study and the BP monitors
used have previously been described in a conference
paper.14 For this study, six BP monitors were used.
The Welch Allyn 767 (Welch Allyn, Skaneateles Falls,
New York, USA), the Omron M7 (Omron, Kyoto,
Japan), the Withings Wireless Blood Pressure Monitor
(Withings, Issy-les-Moulineaux, France), iHealth BP5
(iHealth Lab, Inc., Mountain View, California, USA),
QardioArm (Qardio Inc., San Francisco, California,
USA) and the iHealth BP7 (iHealth Lab, Inc.,
Mountain View, California, USA). All devices bear a
Conformité Européenne (CE) mark and are approved by
the Food and Drug Administration (FDA). The Withings
Wireless Blood Pressure Monitor, QardioArm, iHealth
BP5 and iHealth BP7 are all automated oscillometric
devices that are smartphone-compatible. These four BP
monitors communicate with the smartphone via
Bluetooth. Inflation and deflation is automated and
started by a command from the smartphone. Results of
measurements are sent to the device’s dedicated smart-
phone application (app). The Withings Wireless Blood
Pressure Monitor, the QardioArm and the iHealth BP5
are placed around the bare upper arm of the patient.
The iHealth BP7 is placed around the bare wrist of the
patient. The Omron M7 is an automated oscillometric
device. It is placed around the bare upper arm of the
patient. Inflation and deflation are automated and started
by pushing a button on the device. The Omron M7 is not
smartphone compatible.
The Welch Allyn 767 is a handheld aneroid sphygmo-
manometer. It is placed around the bare upper arm of the
patient. The Welch Allyn 767 has to be applied by a
trained physician. The device has to be pumped up until
the pressure is 10mmHg higher than the systolic BP of the
patients. While deflating, a trained physician needs to aus-
cultate the Korotkoff sounds at the elbow joint. Upon
hearing the first Korotkoff sounds, the systolic BP can
be determined. When the Korotkoff sounds disappear,
the diastolic BP can be determined.15
Study procedures
Patients were taken to a separate, quiet room. They were
asked to sit down and relax for at least five minutes.
During these five minutes, the order of applying the
devices was randomised. For randomisation, a website
(www.randomizer.org) was used. After five minutes of
rest, the devices were, one-by-one, applied to the patient.
To assure that the devices were applied according to the
device manufacturer’s instruction manual, a project-
dedicated healthcare professional applied the device. The
arm of patient’s preference was used. All devices were
applied to the same arm of the patient. Patients were
not allowed to talk or drink during the measurements.
The Omron M7, the Withings Wireless Blood
Pressure Monitor, the iHealth BP5, the QardioArm
and the iHealth BP7 were applied by one of the investiga-
tors (RWT). The Welch Allyn 767 was applied by an
independent trained physician (DCE), who was blinded
to the outcomes of the other measurements. The patient
was blinded to all results of all measurements. After the
last device last measurement, results of all measure-
ments were discussed with the patient. After a device was
applied, it was inflated and deflated three times consecu-
tively, generating three systolic BPs and three diastolic
BPs. The average of these three systolic BP measurements
was taken as systolic and the average of these three
diastolic BP measurements was taken as diastolic BP.
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Statistical analysis
IBM SPSS Statistics for Windows, version 23 (IBM Corp.,
Armonk, New York, USA) was used for statistical
analysis. Continuous variables were presented as mean
standard deviation or as medians with interquartile range
(IQR). The analyses were based on the repeated measures
design with correlated BPs within patients. Linear mixed
models were applied to accommodate this design to com-
pare mean BPs and the variation (variances) of measure-
ments among devices. A p-value of less than 0.05 was
considered statistically significant. The variances of the
measurements within devices were compared within
linear mixed models by likelihood ratio tests comparing
models with equal variances versus models with unequal
variances within an appropriate chi-square distribution.
Sample size calculation
The power calculation was done in PASS (PASS 15.
NCSS, LLC. Kaysville, Utah, USA, ncss.com/software/
pass) and was based on paired t-tests of smartphone
device measurements against the measurements of the
standard device, assuming a clinically relevant difference
of 5mmHg, a standard deviation of the measurements of
11.4 and a within-patient Pearson’s correlation of 0.8.
The calculated sample size was 43 patients.
Ethical conduct
This study was done in accordance with the Declaration
of Helsinki and Good Clinical Practice Guidelines. The
study was approved by the local Research and Ethical
Board. All study participants provided written informed
consent before participation. All devices for this study
were bought from the manufacturers. No manufacturer
had a role in the study design, conduction of the study,




Atotal of 43 study participants (79%male)were included in
the study. Mean age was 62.7 11.3 (range 39.5–81.6).
Median body mass index (BMI) was 26.6 (interquartile
range (IQR) 24.2–29.3). Themean systolic BP (asmeasured
by the Welch Allyn 767) was 119 14 (minimum–max-
imum range 97–160). The mean diastolic BP was 71 8
(minimum–maximum range 50–90). All measurements
yielded 258 systolic BPs and 258 diastolic BPs (Figure 1).
Comparison of means
The average systolic BP measured by Welch Allyn was
118.9. The average systolic BP was þ0.25 (95% confidence
interval (CI) (–2.9–2.4), p¼ 0.856) as measured by Omron,
was þ5.0 (95% CI (2.3–7.7), p< 0.001) as measured by
iHealth BP5, was þ7.1 (95% CI (4.4–9.7), p< 0.001) as
measured by iHealth BP7, was þ4.1 (95% CI (1.3–6.8),
p¼ 0.004) as measured by Qardio and was þ3.2 (95% CI
(0.5–5.9), p¼ 0.022) as measured by Withings. These
results are summarised in Table 1.
The average diastolic BP measured by Welch Allyn
was 71.2. The average diastolic BP was þ3.2 (95% CI
(1.7–4.5), p< 0.001) as measured by Omron, was þ3.9
(95% CI (2.5–5.3), p< 0.001) as measured by iHealth
BP5, was þ6.7 (95% CI (5.3–8.1), p< 0.001) as measured
by iHealth BP7, was þ2.9 (95% CI (1.5–4.4), p< 0.001) as
measured by Qardio and was þ0.7 (95% CI (–0.7–2.2),
p¼ 0.324) as measured by Withings. These results are
summarised in Table 2.
Comparison of means of smartphone
compatible monitors
The average systolic BP measured by Withings was 122.1.
Differences with iHealth BP5 and Qardio were not
Figure 1. Scatterplot of the 258 measurements by iHealth BP5,
iHealth BP7, Omron M7, Qardio, Welch Allyn and Withings. The
x-axis displays the systolic blood pressure (SBP). The y-axis displays
the diastolic blood pressure (DBP). The lines displayed are the
regression lines per device.
Table 1. Results of systolic blood pressure (BP) measurements of











Omron 118.6 0.25 (–2.9–2.4) p¼ 0.856
iHealth BP5 124.0 þ5.0 (2.3–7.7) p< 0.001
iHealth BP7 126.0 þ7.1 (4.4–9.7) p< 0.001
Qardio 123.0 þ4.1 (1.3–6.8) p¼ 0.004
Withings 122.1 þ3.2 (0.5–5.9) p¼ 0.022
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significant (p¼ 0.193 and p¼ 0.547 respectively), while the
difference with iHealth BP7 was significant (p¼ 0.006).
These results are summarised in Table 3.
The average diastolic BP measured by Withings was
71.9. Differences with iHealth BP5, iHealth BP7 and
Qardio were all statistically significant (p< 0.001,
p< 0.001 and p¼ 0.003 respectively). These results are
summarised in Table 4.
Measurement variability of the devices, systolic BP
The statistical model assuming equal variances of the sys-
tolic BPs among devices was tested against the alternative
model of unequal variances by comparing the respective
2 (log-likelihoods) within the appropriate linear mixed
model. The difference of 10.603 was smaller than the crit-
ical value of 11.070 of a chi-square (d.f.¼ 5) distribution
and therefore not significant.
Measurement variability of the devices, diastolic BP
For diastolic blood pressures the difference of 23.048 of
the two 2 (log-likelihoods) was larger than the critical
value of 11.070 of a chi-square (d.f.¼ 5) distribution and
therefore was significant.
Discussion
In the current study, inter-, and intra-device variability of
four smartphone-compatible blood pressure monitors was
compared with a handheld sphygmomanometer, a non-
smartphone-compatible oscillometric device and with
each other. These monitors may be suitable for home
monitoring, as their usage does not require assistance of
trained healthcare staff and measurement results can be
transferred automatically.
The results demonstrate that, compared with the
conventional handheld sphygmomanometer and a non-
smartphone-compatible oscillometric device, compatible
BP monitors tend to yield higher systolic and diastolic
BPs. These differences were all statistically significant,
except for the diastolic BP by the Withings Wireless
Blood Pressure Monitor. However, these differences
were also within the predefined range of 5mmHg, except
for the iHealth BP7. Intra-device variability was non-
significant for systolic BP, but was significant for
diastolic BP.
Validation studies of the devices used in the study have
been published previously.10–13 These studies were all
done in accordance with the European Society of
Hypertension protocol, in which a device is compared
with a mercury sphygmomanometer following a standar-
dised protocol.16 These studies show a higher mean sys-
tolic and diastolic BP for the Omron M7,10 but a lower
mean systolic and diastolic BP for the Withings Wireless
Blood Pressure Monitor,13 the iHealth BP512 and the
iHealth BP7.11 This is in contrast with the results of this
study, in which these devices yielded higher mean systolic
and diastolic BPs. This might be explained by the fact that
in this study an overweight population was studied.
Oscillometric devices tend to be more inaccurate in
patients with a higher BMI.17
To our knowledge, studies comparing more than one
oscillometric BP monitor with the gold standard have not
been performed previously. Studies validating more than
one oscillometric device do exist,13,18 however, all these
studies describe several independently executed validation
studies. These studies do not describe the validation of
more than one oscillometric device in the same study
population.
The fact that smartphone-compatible BP monitors tend
to yield higher BPs, makes them less suitable for on-the-
spot measurements during outpatient clinic visits.
However, the fact that these overestimates are within the
5mmHg range, and the intra-device consistency of the
systolic BP measurements, makes them suitable for
home monitoring. With daily measurements, more
Table 2. Results of diastolic blood pressure (BP) measurements of










Omron 74.4 þ3.2 (1.7–4.5) p< 0.001
iHealth BP5 75.1 þ3.9 (2.5–5.3) p< 0.001
iHealth BP7 77.9 þ6.7 (5.3–8.1) p< 0.001
Qardio 74.1 þ2.9 (1.5–4.4) p< 0.001
Withings 71.9 þ0.7 (0.7–2.2) p¼ 0.324
Table 3. Results of systolic blood pressure (BP) measurements of
smartphone-compatible monitors, compared with the Withings










iHealth BP5 124.0 þ1.9 (0.9–4.5) p¼ 0.193
iHealth BP7 126.0 þ3.9 (1.1–6.6) p¼ 0.006
Qardio 123.0 þ0.9 (1.9–3.6) p¼ 0.547
Table 4. Results of diastolic blood pressure (BP) measurements of
smartphone-compatible monitors, compared with the Withings










iHealth BP5 124.0 þ3.2 (1.7–4.6) p< 0.001
iHealth BP7 126.0 þ3.9 (4.5–7.4) p< 0.001
Qardio 123.0 þ0.9 (0.7–3.7) p¼ 0.003
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measurement results can be generated and the physician
can adjust the therapeutic regimen on a trend instead on
an on-the-spot measurement. It is hypothesised that these
monitors give a reliable average systolic and diastolic BP
based on daily measurements and the possibility of an
incorrect therapeutic regimen change (defined as a phys-
ician changing the medication while the patient’s BP has
not changed) is small. It has already been shown that
more frequent home monitoring of BP, and changing
therapeutic regimen when necessary, improves BP
control.6
There are, however, possibilities for further research.
First, the results of this study need to be corroborated
in a home situation, preferably with the patients using
the devices themselves and without the assistance of
trained healthcare staff. Second, the reliability of the BP
monitors has to be investigated in the long-term. In a
hospital setting, BP monitors are calibrated approxi-
mately every two years.19 However, as long-term compari-
son results are lacking, it remains unknown whether this
calibration time-frame can be applied to oscillometric
devices which are used in a home setting as well.19
Lastly, our study was conducted in adults with known
cardiovascular disease. The results need to be corrobo-
rated in other populations, such as children and pregnant
women.
Some limitations of our study design need to be men-
tioned. First of all, this study is meant to compare the four
smartphone-compatible blood pressure measurements. It
is not the primary purpose of this study to validate the
devices. All devices have been validated previously.10–13
Therefore, the results should only be used for comparison
purposes. Secondly, although the BP range of our popu-
lation was quite wide, it need to be mentioned that meas-
urements were done in a specific population. All patients
were followed-up for myocardial infarction, and were
therefore on antihypertensive drugs. Thirdly, no patients
with (a history of) irregular heart rhythms were included
in our study. All patients had regular sinus rhythm when
they participated in the study. This means that the com-
parison made in our study cannot be extrapolated to
patients who do have irregular heart rhythms. Lastly,
our patients were tested in an outpatient clinic of a tertiary
care centre. A researcher was present during all measure-
ments. Although patients applied the devices themselves,
patients were corrected in case of any mistakes in applying
the devices.
Conclusion
In conclusion, we present a study comparing four vali-
dated smartphone-compatible BP monitors. Average
inter-device variability was shown to be statistically sig-
nificant, however, within the predefined range of 5mmHg
for both systolic and diastolic BPs. Furthermore, devices
showed comparable consistency for systolic BP, but less so
for diastolic BP.
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